marketcaparena
Search

    ETON

    Eton Pharmaceuticals, Inc.

    Company overview

    Market capitalization
    $1.69B
    Employees
    44
    Latest publication
    2026-09-29
    About Eton Pharmaceuticals, Inc.

    Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USDQ3 20232023-09-30 · USD
    Total Revenue37,589,000USD24,266,000USD21,281,000USD17,282,000USD11,647,000USD10,324,000USD7,966,000USD7,028,000USD
    Cost Of Revenue12,176,000USD9,531,000USD8,181,000USD7,421,000USD5,171,000USD4,022,000USD2,959,000USD2,625,000USD
    Gross Profit25,413,000USD14,735,000USD13,100,000USD9,861,000USD6,476,000USD6,302,000USD5,007,000USD4,403,000USD
    Research Development993,000USD1,875,000USD1,780,000USD1,161,000USD871,000USD505,000USD651,000USD615,000USD
    Selling General Administrative11,626,000USD10,446,000USD8,856,000USD9,170,000USD6,718,000USD5,288,000USD5,156,000USD4,336,000USD
    General And Administrative Expenses11,626,000USD———————
    Total Operating Expenses12,619,000USD12,321,000USD10,636,000USD10,331,000USD5,847,000USD5,793,000USD5,807,000USD4,951,000USD
    Operating Income12,794,000USD2,414,000USD2,464,000USD-470,000USD629,000USD509,000USD-800,000USD-548,000USD
    Total Other Income Expense Net-1,076,000USD-840,000USD-1,050,000USD-1,028,000USD-1,140,000USD-8,000USD-11,000USD-31,000USD
    Income Before Tax11,718,000USD1,574,000USD1,414,000USD-1,498,000USD-511,000USD501,000USD-811,000USD-579,000USD
    Income Tax Expense140,000USD20,000USD-69,000USD74,000USD87,000USD-126,000USD208,724USD241,586USD
    Net Income11,578,000USD1,554,000USD1,483,000USD-1,572,000USD-598,000USD627,000USD-811,000USD-579,000USD
    Interest Expense—840,000USD1,208,000USD1,163,000USD1,333,000USD8,000USD11,000USD31,000USD
    Net Interest Income—-840,000USD-1,050,000USD-1,028,000USD-1,140,000USD-8,000USD-11,000USD-31,000USD
    Tax Provision—20,000USD-69,000USD74,000USD87,000USD-126,000USD0USD0USD
    Net Income From Continuing Ops—1,554,000USD1,483,000USD-1,572,000USD-598,000USD627,000USD-811,000USD-579,000USD
    Ebit—734,000USD2,622,000USD-335,000USD-511,000USD509,000USD-800,000USD-548,000USD
    Ebitda—1,865,000USD3,638,999USD678,000USD-156,000USD787,000USD-566,000USD-357,000USD
    Depreciation And Amortization—1,131,000USD1,016,999USD1,013,000USD355,000USD278,000USD234,000USD191,000USD
    Reconciled Depreciation—1,131,000USD1,017,000USD1,013,000USD355,000USD278,000USD252,000USD202,000USD
    Unclassified Operating Expenses————-1,742,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue79,950,000USD39,000USD959,000USD0USD
    Cost Of Revenue37,210,000USD286,000USD453,000USD13,000USD
    Gross Profit42,740,000USD-247,000USD506,000USD-13,000USD
    Research Development7,765,000USD14,104,000USD11,555,000USD3,930,000USD
    Selling General Administrative35,819,000USD12,760,000USD7,552,000USD4,830,000USD
    Total Operating Expenses42,668,000USD26,864,000USD19,107,000USD7,137,000USD
    Operating Income72,000USD-27,111,000USD-18,601,000USD-7,150,000USD
    Interest Expense4,781,000USD889,000USD281,000USD0USD
    Net Interest Income-3,714,000USD-859,000USD281,000USD—
    Income Before Tax-4,558,000USD-27,970,000USD-18,320,000USD-7,156,000USD
    Income Tax Expense43,000USD859,000USD-281,000USD0USD
    Tax Provision43,000USD0USD0USD—
    Net Income-4,601,000USD-27,970,000USD-18,320,000USD-7,156,000USD
    Net Income From Continuing Ops-4,601,000USD-27,970,000USD-18,320,000USD-10,734,000USD
    Ebit223,000USD-27,111,000USD-18,601,000USD-7,156,000USD
    Ebitda4,266,999USD-26,460,000USD-18,154,000USD-7,143,000USD
    Depreciation And Amortization4,043,999USD651,000USD447,000USD13,000USD
    Reconciled Depreciation4,044,000USD651,000USD447,000USD—
    Total Other Income Expense Net-4,630,000USD-859,000USD281,000USD-6,000USD
    Non Operating Income Net Other—-859,000USD281,000USD—
    Net Income Applicable To Common Shares—-27,970,000USD-18,320,000USD-12,958,500USD
    Interest Income——281,000USD—
    Unclassified Operating Expenses———-1,623,000USD
    Minority Interest———0USD
    Discontinued Operations———0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets115,807,000USD97,710,000USD92,114,000USD104,510,000USD101,676,000USD84,032,000USD76,123,000USD35,841,000USD
    Cash And Equivalents26,845,000USD———————
    Total Current Assets68,599,000USD53,245,000USD60,581,000USD72,000,000USD68,443,000USD49,960,000USD41,021,000USD29,749,000USD
    Other Current Assets6,725,000USD5,709,000USD7,463,000USD4,942,000USD4,820,000USD2,519,000USD5,492,000USD1,959,000USD
    Other Non Current Assets64,000USD———————
    Total Liabilities69,222,000USD———————
    Total Current Liabilities45,124,000USD44,179,000USD38,490,000USD44,183,000USD38,596,000USD25,350,000USD19,947,000USD19,734,000USD
    Other Current Liabilities10,925,000USD———————
    Other Non Current Liabilities3,937,000USD———————
    Total Stockholder Equity46,585,000USD30,615,000USD26,154,000USD23,126,000USD23,961,000USD24,450,000USD24,428,000USD15,981,000USD
    Total Equity Including Noncontrolling Interest46,585,000USD———————
    Long Term Debt19,078,000USD18,939,000USD21,769,000USD27,591,000USD27,409,000USD29,992,000USD29,811,000USD—
    Net Receivables24,886,000USD13,408,000USD11,757,000USD13,082,000USD14,453,000USD16,400,000USD5,361,000USD5,591,000USD
    Inventory10,143,000USD14,467,000USD15,419,000USD16,855,000USD23,791,000USD13,621,000USD15,232,000USD1,938,000USD
    Property Plant Equipment Net1,466,000USD673,000USD636,000USD613,000USD342,000USD180,000USD209,000USD226,000USD
    Intangible Assets45,678,000USD43,738,000USD30,878,000USD31,878,000USD32,879,000USD33,880,000USD34,881,000USD5,854,000USD
    Accounts Payable14,405,000USD13,485,000USD10,976,000USD14,259,000USD12,142,000USD4,872,000USD4,167,000USD2,684,000USD
    Short Term Debt8,825,000USD11,808,000USD8,789,000USD2,776,000USD2,769,000USD77,000USD76,000USD4,200,000USD
    Common Stock28,000USD27,000USD27,000USD27,000USD27,000USD27,000USD27,000USD26,000USD
    Retained Earnings-99,362,000USD-110,940,000USD-112,494,000USD-113,977,000USD-112,050,000USD-109,465,000USD-107,893,000USD-107,295,000USD
    Total Liab—67,095,000USD65,960,000USD81,384,000USD77,715,000USD59,582,000USD51,695,000USD19,860,000USD
    Other Current Liab—18,886,000USD18,725,000USD27,148,000USD23,355,000USD20,071,000USD15,704,000USD12,925,000USD
    Capital Stock—27,000USD27,000USD27,000USD27,000USD27,000USD27,000USD26,000USD
    Cash—19,661,000USD25,942,000USD37,121,000USD25,379,000USD17,420,000USD14,936,000USD20,261,000USD
    Cash And Short Term Investments—19,661,000USD25,942,000USD37,121,000USD25,379,000USD17,420,000USD14,936,000USD20,261,000USD
    Net Debt—-7,413,000USD-16,693,000USD-33,865,000USD5,314,000USD12,736,000USD15,058,000USD-15,935,000USD
    Short Long Term Debt—11,808,000USD8,789,000USD2,776,000USD2,769,000USD——4,125,000USD
    Short Long Term Debt Total—12,248,000USD9,249,000USD3,256,000USD30,670,000USD30,156,000USD29,994,000USD4,326,000USD
    Property Plant Equipment Gross—673,000USD1,122,000USD613,000USD342,000USD180,000USD655,000USD660,000USD
    Common Stock Shares Outstanding—31,547,000shares26,908,000shares26,893,000shares26,893,000shares26,886,000shares26,136,000shares26,550,000shares
    Non Current Assets Total—44,465,000USD31,533,000USD32,510,000USD33,233,000USD34,072,000USD35,102,000USD6,092,000USD
    Non Current Liabilities Total—22,916,000USD27,470,000USD37,201,000USD39,119,000USD34,232,000USD31,748,000USD126,000USD
    Non Current Liabilities Other—3,537,000USD5,241,000USD3,942,000USD4,269,000USD4,153,000USD1,830,000USD—
    Non Currrent Assets Other—54,000USD19,000USD19,000USD12,000USD12,000USD12,000USD12,000USD
    Net Working Capital—9,066,000USD22,091,000USD27,817,000USD29,847,000USD24,610,000USD21,074,000USD10,015,000USD
    Unclassified Current Liabilities—-11,808,000USD-8,789,000USD-2,776,000USD-2,769,000USD——-4,200,000USD
    Unclassified Equity—141,501,000USD138,594,000USD137,049,000USD135,957,000USD133,861,000USD132,267,000USD123,224,000USD
    Unclassified Non Current Liabilities———5,668,000USD7,441,000USD———
    Current Deferred Revenue————330,000USD330,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets92,114,000USD76,123,000USD31,740,000USD25,030,000USD27,465,000USD26,319,000USD17,072,000USD28,327,000USD
    Intangible Assets30,878,000USD34,881,000USD4,739,000USD4,754,000USD3,621,000USD575,000USD725,000USD0USD
    Other Current Assets7,463,000USD5,492,000USD1,129,000USD1,290,000USD3,177,000USD2,116,000USD2,090,000USD767,000USD
    Total Liab65,960,000USD51,695,000USD16,263,000USD11,952,000USD9,835,000USD10,656,000USD6,522,000USD2,024,000USD
    Total Stockholder Equity26,154,000USD24,428,000USD15,477,000USD13,078,000USD17,630,000USD15,663,000USD10,550,000USD26,303,000USD
    Other Current Liab18,725,000USD15,704,000USD9,013,000USD3,662,000USD1,366,000USD1,170,000USD1,388,000USD603,000USD
    Common Stock27,000USD27,000USD26,000USD25,000USD25,000USD24,000USD18,000USD18,000USD
    Capital Stock27,000USD27,000USD26,000USD25,000USD25,000USD24,000USD18,000USD18,000USD
    Retained Earnings-112,494,000USD-107,893,000USD-104,070,000USD-103,134,000USD-94,113,000USD-92,158,000USD-64,188,000USD-45,868,000USD
    Cash25,942,000USD14,936,000USD21,388,000USD16,305,000USD14,406,000USD21,295,000USD12,066,000USD26,735,000USD
    Cash And Short Term Investments25,942,000USD14,936,000USD21,388,000USD16,305,000USD14,406,000USD21,295,000USD12,066,000USD26,735,000USD
    Total Current Assets60,581,000USD41,021,000USD26,839,000USD20,004,000USD23,604,000USD24,701,000USD15,009,000USD27,502,000USD
    Total Current Liabilities38,490,000USD19,947,000USD16,241,000USD6,461,000USD4,558,000USD3,794,000USD1,963,000USD2,024,000USD
    Net Debt5,076,000USD15,058,000USD-15,986,000USD-9,781,000USD-7,711,000USD-14,153,000USD-7,507,000USD-26,735,000USD
    Short Term Debt8,789,000USD76,000USD5,380,000USD1,033,000USD1,418,000USD280,000USD133,000USD0USD
    Short Long Term Debt8,789,000USD—5,380,000USD1,033,000USD1,418,000USD280,000USD—0USD
    Short Long Term Debt Total31,018,000USD29,994,000USD5,402,000USD6,524,000USD6,695,000USD7,142,000USD4,673,000USD—
    Long Term Debt21,769,000USD29,811,000USD—5,384,000USD5,262,000USD6,763,000USD4,540,000USD0USD
    Net Receivables11,757,000USD5,361,000USD3,411,000USD1,852,000USD5,471,000USD48,000USD473,000USD—
    Inventory15,419,000USD15,232,000USD911,000USD557,000USD550,000USD1,242,000USD380,000USD0USD
    Accounts Payable10,976,000USD4,167,000USD1,848,000USD1,766,000USD1,774,000USD2,344,000USD575,000USD1,421,000USD
    Property Plant Equipment Net636,000USD209,000USD150,000USD260,000USD219,000USD1,003,000USD1,277,000USD773,000USD
    Property Plant Equipment Gross1,122,000USD655,000USD545,000USD260,000USD219,000USD1,003,000USD1,277,000USD773,000USD
    Common Stock Shares Outstanding26,908,000shares25,895,000shares25,645,366shares25,146,000shares25,207,000shares21,010,000shares17,761,000shares6,418,000shares
    Non Current Assets Total31,533,000USD35,102,000USD4,901,000USD5,026,000USD3,861,000USD1,618,000USD2,063,000USD825,000USD
    Non Current Liabilities Total27,470,000USD31,748,000USD22,000USD5,491,000USD5,277,000USD6,862,000USD4,559,000USD1,421,000USD
    Non Current Liabilities Other5,241,000USD1,830,000USD—107,000USD—330,000USD19,000USD—
    Non Currrent Assets Other19,000USD12,000USD12,000USD12,000USD21,000USD40,000USD61,000USD52,000USD
    Net Working Capital22,091,000USD21,074,000USD10,598,000USD13,543,000USD19,046,000USD20,907,000USD13,046,000USD25,478,000USD
    Unclassified Current Liabilities-8,789,000USD—-5,380,000USD-1,033,000USD-1,418,000USD———
    Unclassified Equity138,594,000USD132,267,000USD119,495,000USD116,162,000USD111,693,000USD107,773,000USD75,047,000USD72,135,000USD
    Other Assets———12,000USD21,000USD232,000USD61,000USD52,000USD
    Net Tangible Assets———8,324,000USD14,009,000USD15,088,000USD9,825,000USD26,303,000USD
    Current Deferred Revenue——————-133,000USD—
    Accumulated Other Comprehensive Income——————-345,000USD0USD
    Deferred Long Term Liab———————0USD
    Other Liab———————0USD
    Good Will———————0USD
    Long Term Investments———————0USD
    Short Term Investments———————0USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    Unclassified Non Current Liabilities———————1,421,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,517,000USD
    Stock Based Compensation2,986,000USD
    Change To Account Receivables-13,129,000USD
    Change To Inventory4,725,000USD
    Change To Liabilities4,133,000USD
    Change In Working Capital-4,236,000USD
    Operating Cash Flow14,660,000USD
    Capital Expenditures-70,000USD
    Unclassified Investing Cash Flow-15,000,000USD
    Investing Cash Flow-15,070,000USD
    Common Stock Issuance270,000USD
    Unclassified Financing Cash Flow1,043,000USD
    Financing Cash Flow1,313,000USD
    Change In Cash903,000USD
    End Cash Flow26,845,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income1,554,000USD1,483,000USD-1,927,000USD-2,585,000USD-1,572,000USD-598,000USD627,000USD-3,041,000USD
    Depreciation1,131,000USD1,017,000USD1,009,000USD1,005,000USD1,013,000USD355,000USD278,000USD261,000USD
    Stock Based Compensation1,518,000USD1,124,000USD1,092,000USD2,096,000USD1,200,000USD782,000USD722,000USD840,000USD
    Other Non Cash Items711,000USD2,199,000USD1,508,000USD1,268,000USD1,453,000USD1,056,000USD39,000USD59,000USD
    Change To Account Receivables-1,651,000USD1,325,000USD1,371,000USD1,947,000USD-11,039,000USD-939,000USD-717,000USD-633,000USD
    Change To Inventory1,406,000USD-581,000USD5,614,000USD-11,377,000USD468,000USD-283,000USD130,000USD250,000USD
    Change In Working Capital2,491,000USD-17,374,000USD10,344,000USD6,175,000USD-4,000USD-2,360,000USD1,286,000USD3,136,000USD
    Total Cash From Operating Activities7,405,000USD-11,551,000USD12,026,000USD7,959,000USD2,090,000USD-765,000USD2,952,000USD1,255,000USD
    Capital Expenditures-75,000USD-49,000USD-284,000USD0USD0USD-12,000USD-1,868,000USD0USD
    Free Cash Flow7,330,000USD-11,600,000USD11,742,000USD7,959,000USD2,090,000USD-777,000USD2,952,000USD1,255,000USD
    Total Cashflows From Investing Activities-15,075,000USD-49,000USD-284,000USD——-38,132,000USD1,868,000USD—
    Total Cash From Financing Activities1,389,000USD421,000USD0USD0USD394,000USD33,572,000USD-385,000USD-216,000USD
    Change In Cash-6,281,000USD-11,179,000USD11,742,000USD7,959,000USD2,484,000USD-5,325,000USD2,567,000USD1,039,000USD
    Begin Period Cash Flow25,942,000USD37,121,000USD25,379,000USD17,420,000USD14,936,000USD20,261,000USD17,694,000USD16,655,000USD
    End Period Cash Flow19,661,000USD25,942,000USD37,121,000USD25,379,000USD17,420,000USD14,936,000USD20,261,000USD17,694,000USD
    Unclassified Investing Cash Flow-15,000,000USD————8,132,000USD5,604,000USD—
    Net Borrowings—0USD0USD0USD0USD25,309,000USD-385,000USD—
    Other Cashflows From Financing Activities—217,000USD——394,000USD248,000USD-385,000USD169,000USD
    Investments——-284,000USD0USD0USD-38,132,000USD0USD0USD
    Other Cashflows From Investing Activities—————-8,120,000USD-1,868,000USD—
    Unclassified Financing Cash Flow—————8,015,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-4,601,000USD-3,823,000USD-936,000USD-9,021,000USD-1,955,000USD-27,970,000USD-18,320,000USD-12,740,000USD
    Depreciation4,044,000USD1,146,000USD901,000USD1,774,000USD462,000USD651,000USD447,000USD63,000USD
    Stock Based Compensation5,512,000USD3,165,000USD3,137,000USD4,218,000USD3,381,000USD2,576,000USD1,888,000USD1,850,000USD
    Other Non Cash Items6,428,000USD1,179,000USD184,000USD189,000USD148,000USD1,385,000USD16,000USD2,583,000USD
    Change To Account Receivables-6,396,000USD-3,118,000USD-1,559,000USD3,619,000USD-5,423,000USD425,000USD-473,000USD-473,000USD
    Change To Inventory-5,876,000USD-1,310,000USD-354,000USD-7,000USD692,000USD-862,000USD-380,000USD-380,000USD
    Change In Working Capital-859,000USD-698,000USD3,529,000USD7,661,000USD-6,211,000USD1,012,000USD-2,057,000USD99,000USD
    Total Cash From Operating Activities10,524,000USD969,000USD6,815,000USD4,821,000USD-4,721,000USD-22,346,000USD-18,026,000USD-8,145,000USD
    Capital Expenditures-333,000USD-26,000USD-775,000USD-2,788,000USD-3,259,000USD-50,000USD-1,846,000USD-236,000USD
    Free Cash Flow10,191,000USD943,000USD6,040,000USD2,033,000USD-7,980,000USD-22,396,000USD-19,872,000USD-8,381,000USD
    Total Cashflows From Investing Activities-333,000USD-40,014,000USD-775,000USD-2,788,000USD-2,559,000USD-50,000USD-1,846,000USD-236,000USD
    Net Borrowings0USD24,154,000USD-1,155,000USD-385,000USD-150,000USD2,476,000USD4,750,000USD4,750,000USD
    Total Cash From Financing Activities815,000USD32,593,000USD-957,000USD-134,000USD391,000USD31,625,000USD5,203,000USD21,960,000USD
    Issuance Of Capital Stock0USD7,000,000USD0USD0USD21,026,000USD28,782,000USD7,459,000USD22,803,000USD
    Change In Cash11,006,000USD-6,452,000USD5,083,000USD1,899,000USD-6,889,000USD9,229,000USD-14,669,000USD13,579,000USD
    Begin Period Cash Flow14,936,000USD21,388,000USD16,305,000USD14,406,000USD21,295,000USD12,066,000USD26,735,000USD13,156,000USD
    End Period Cash Flow25,942,000USD14,936,000USD21,388,000USD16,305,000USD14,406,000USD21,295,000USD12,066,000USD26,735,000USD
    Other Cashflows From Financing Activities217,000USD248,000USD198,000USD251,000USD541,000USD367,000USD453,000USD205,000USD
    Investments—-40,014,000USD-775,000USD-2,788,000USD-2,559,000USD-50,000USD-1,846,000USD-236,000USD
    Other Cashflows From Investing Activities—-9,988,000USD—-2,750,000USD-2,550,000USD—-750,000USD0USD
    Unclassified Investing Cash Flow—10,014,000USD—5,538,000USD5,809,000USD—2,596,000USD—
    Unclassified Financing Cash Flow—1,191,000USD——-21,026,000USD——-3,907,000USD
    Change To Liabilities———2,209,000USD-570,000USD1,769,000USD157,000USD762,000USD
    Sale Purchase Of Stock———251,000USD—29,149,000USD453,000USD21,960,000USD
    Cash And Cash Equivalents Changes———1,899,000USD—9,229,000USD-14,669,000USD13,579,000USD
    Dividends Paid———————-1,048,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductLicense0USD0001437749-26-017064
    Q1 2026Quarterly · 2026-03-31ProductProduct Sales And Royalties24,266,000USD0001437749-26-017064
    Q4 2025Quarterly · 2025-12-31ProductLicense0USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct Sales And Royalties21,281,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductLicense3,286,000USD0001437749-26-009059
    FY 2025Yearly · 2025-12-31ProductProduct Sales And Royalties76,664,000USD0001437749-26-009059
    Q3 2025Quarterly · 2025-09-30ProductLicense0USD0001437749-25-033619
    Q3 2025Quarterly · 2025-09-30ProductProduct Sales And Royalties22,459,000USD0001437749-25-033619
    Q2 2025Quarterly · 2025-06-30ProductLicense0USD0001437749-25-025444
    Q2 2025Quarterly · 2025-06-30ProductProduct Sales And Royalties18,928,000USD0001437749-25-025444
    Q1 2025Quarterly · 2025-03-31ProductLicense3,286,000USD0001437749-26-017064
    Q1 2025Quarterly · 2025-03-31ProductProduct Sales And Royalties13,996,000USD0001437749-26-017064
    Q4 2024Quarterly · 2024-12-31ProductLicense0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct Sales And Royalties11,647,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductLicense500,000USD0001437749-26-009059
    FY 2024Yearly · 2024-12-31ProductProduct Sales And Royalties38,511,000USD0001437749-26-009059
    Q3 2024Quarterly · 2024-09-30ProductLicense500,000USD0001437749-25-033619
    Q3 2024Quarterly · 2024-09-30ProductProduct Sales And Royalties9,824,000USD0001437749-25-033619
    Q2 2024Quarterly · 2024-06-30ProductLicense0USD0001437749-25-025444
    Q2 2024Quarterly · 2024-06-30ProductProduct Sales And Royalties9,074,000USD0001437749-25-025444
    FY 2023Yearly · 2023-12-31ProductLicense5,500,000USD0001437749-26-009059
    FY 2023Yearly · 2023-12-31ProductProduct Sales And Royalties26,142,000USD0001437749-26-009059
    FY 2022Yearly · 2022-12-31ProductLicense10,000,000USD0001437749-25-008136
    FY 2022Yearly · 2022-12-31ProductProduct Sales And Royalties11,251,000USD0001437749-25-008136
    FY 2021Yearly · 2021-12-31ProductLicense19,000,000USD0001437749-24-007853
    FY 2021Yearly · 2021-12-31ProductProduct Sales And Royalties2,832,000USD0001437749-24-007853
    FY 2019Yearly · 2019-12-31ProductLicensing Revenue500,000USD0001493152-22-006990
    FY 2019Yearly · 2019-12-31ProductProduct459,000USD0001493152-22-006990

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.